|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 1 May 2023, 8:12. The announcement is marked as price sensitive, and is 2 page(s) in length and 238.86kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.563% short sold according to ASIC data. It was ranked the 312th most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Approval to start Efti & Bavencio trial in urothelial cancer | 1 May 2023, 8:12 |
| Immutep Quarterly Activities Report and Appendix 4C | 27 April 2023, 8:04 |
| Immutep to announce new TACTI-002 data at ASCO 2023 | 27 April 2023, 8:02 |
| Immutep appoints Dr Florian Vogl as Chief Medical Officer | 26 April 2023, 8:46 |
You must be logged in to post a reply.
